Trusted Resources: Education
Scientific literature and patient education texts
A Guide to Understanding MPS I (Hurler, Hurler-Scheie, and Scheie Syndromes)
source: National MPS Society
year: 2021
summary/abstract:What Is MPS I?
Mucopolysaccharidosis I (MPS I) is a rare genetic disorder that affects the entire body. It is also known as Hurler syndrome, named after Dr. Gertrude Hurler, a general practitioner, who in 1919 first described a boy and girl with severe symptoms of the condition. In 1962, Dr. Harold Scheie, an ophthalmologist, described individuals who displayed attenuated (less severe) symptoms and primarily were affected by corneal clouding. This apparently new condition was named Scheie syndrome (also temporarily known as MPS V) and was thought to be a different disease from Hurler syndrome. In the 1970s, there were several reports of individuals whose symptoms of intermediate severity did not fit clearly in either syndrome, and consequently, were categorized as Hurler-Scheie syndrome.
If you are a parent of a newly diagnosed child, or someone who has been diagnosed with MPS I yourself, it is important to remember that there is a wide spectrum of severity in how MPS I shows up and progresses:
It can be an attenuated (less severe) form that usually manifests in adolescence and progresses slowly, which is called Scheie syndrome and is less common.
It can be an intermediate form that usually manifests in late childhood, has some features of both the attenuated and severe forms, and progresses at an intermediate pace, which is called Hurler-Scheie syndrome.
read more
Related Content
-
Detecting Lysosomal Storage Disorders By Glycomic Profiling Using Liquid Chromatography Mass SpectrometryUrine and plasma biomarker testing for l...
-
CHOC-Harbor UCLA MPS Multidisciplinary CenterCHOC and Harbor-UCLA Pediatrics together...
-
Quantitative Brain MRI Morphology in Severe and Attenuated Forms of Mucopolysaccharidosis Type ITo assess our hypothesis that brain macr...
-
Evidence of Treatment Benefits in Patients With Mucopolysaccharidosis Type I-Hurler in Long-Term Follow-Up Using a N...We developed a brain and spine magnetic ...
-
Fetal Therapies and Trials for Lysosomal Storage Diseases: A Survey of Attitudes of Parents and PatientsLysosomal storage diseases (LSDs) are in...
-
Advances in Approaches to Care and Monitoring of MPS Diseasehttps://www.youtube.com/watch?v=JZSVzeiX...
-
Early and Late Brain Resonance Findings of Two Siblings With Hunter SyndromeMucopolysaccharidosis type II (MPS II) i...